Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma

Na Hee Lee,Meong Hi Son,Young Bae Choi,Eunsang Yi,Ji Won Lee,Keon Hee Yoo,Ki Woong Sung,Hong Hoe Koo

DOI: https://doi.org/10.4143/crt.2015.481

IF: 5.036

2016-10-15

Cancer Research and Treatment

Abstract:PURPOSE: The purpose of this study is to investigate the clinical significance of tyrosine hydroxylase (TH) expression in peripheral blood (PB) at diagnosis in patients with neuroblastoma.MATERIALS AND METHODS: <i>TH</i> mRNA expression in PB was measured by reverse transcription quantitative real-time polymerase chain reaction in 210 patients who were newly diagnosed with neuroblastoma from July 2005 to June 2015 and the clinical significance of <i>TH</i> expression in PB at diagnosis was evaluated.RESULTS: <i>TH</i> expression was positive in 60 patients (28.6%). Fifty of 60 <i>TH</i>-positive patients had metastatic tumors and the remaining 10 had localized tumors. <i>TH</i> expression was associated with high-risk features (i.e., advanced stage, older age, unfavorable pathology, and <i>MYCN</i> amplification) at diagnosis. Among <i>TH</i>-positive patients, higher <i>TH</i> expression level was observed in high-risk patients than in low- or intermediate-risk patients (p=0.035). The probability of 5-year progression-free survival (PFS) was lower in <i>TH</i>-positive patients than in <i>TH</i>-negative patients (63.8±6.9% vs. 94.7±2.1%, p &lt; 0.001). In analysis confined to high-risk patients, the 5-year probability of PFS remained lower in <i>TH</i>-positive patients (55.7±8.2% vs. 89.6±5.8%, p &lt; 0.001). Among <i>TH</i>-positive patients, a higher expression level of <i>TH</i> was associated with a worse outcome. In multivariate analyses, positive <i>TH</i> expression in PB at diagnosis was an independent poor prognostic factor for PFS.CONCLUSION: The treatment intensity should be tailored according to <i>TH</i> expression in PB at diagnosis.

oncology